Business
US FDA approves use of Gilead’s remdesivir for hospitalised coronavirus patients – ABC News
The US Food and Drug Administration approves Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and…
The US Food and Drug Administration has approved Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and only drug approved for the disease in the United States.
- The FDA’s formal approval for remdesivir’s widespread use came hours before the final presidential debate
- However, the World Health Organization found the drug did not have a substantial effect on patients’ length of hospital stays or chances of survival
- Remdesivir will be sold…
Continue Reading
-
General24 hours agoNothing to see here *wink wink*
-
General22 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup
-
Noosa News8 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General12 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia